Nurse Practitioner, Family · Bartow, FL
NPI
1043670771
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1170 Nevermore Cir
Bartow, FL, 33830
Phone (863) 512-1055
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,190
36 services
Medicare patients, 2024
27
Average age 61
Drug cost, 2024
$7.1M
2,403 prescriptions
Company payments, 2025
$294
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeena Mathew was code 99214 (office e&m - established), 36 times for 27 patients. In total Jeena Mathew billed 36 services in 1 codes, and Medicare paid $2,190.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 36 | 27 | $60.84 | $2,190 |
By year: 2022 $2,943 for 69 services; 2023 $2,206 for 46 services; 2024 $2,190 for 36 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeena Mathew prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 1,060 prescriptions and refills. In total Jeena Mathew wrote 2,403 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 1,060 | 1,060 | 159 | $4.0M |
| Tivicay Dolutegravir Sodium | 226 | 226 | 36 | $499K |
| Prezcobix Darunavir/Cobicistat | 182 | 182 | 27 | $426K |
| Dovato Dolutegravir Sodium/Lamivudine | 163 | 163 | 25 | $452K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 82 | 82 | Under 11 | $283K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 71 | 75 | 14 | $333K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 67 | 67 | 13 | $266K |
| Descovy Emtricitabine/Tenofov Alafenam | 65 | 65 | Under 11 | $141K |
| Juluca Dolutegravir/Rilpivirine | 55 | 55 | Under 11 | $180K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 43 | 43 | Under 11 | $150K |
| Evotaz Atazanavir Sulfate/Cobicistat | 42 | 42 | Under 11 | $61K |
| Darunavir Generic | 39 | 39 | Under 11 | $25K |
| Prezista Darunavir | 30 | 30 | Under 11 | $63K |
| Pifeltro Doravirine | 29 | 29 | Under 11 | $49K |
| Isentress Raltegravir Potassium | 28 | 28 | Under 11 | $56K |
Brand drugs: 2,170 claims; generic drugs: 233 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeena Mathew $294 ($294 in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $245.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.